Muzza Marina, Fugazzola Laura
Endocrine Unit, Fondazione IRCCS Ca' Granda Policlinico, Milan, Italy.
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Dept. of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Best Pract Res Clin Endocrinol Metab. 2017 Mar;31(2):225-240. doi: 10.1016/j.beem.2017.04.006. Epub 2017 May 10.
After the identification of thyroid HO generation system (DUOX) and of its maturation factors (DUOXA), defects in DUOX2 and/or DUOXA2 were rapidly recognized as the possible cause of congenital hypothyroidism (CH) due to thyroid dyshormonogenesis. The present Review reports data on the prevalence of DUOX2 mutations, which is variable among different series but invariably high, pointing to DUOX2 defects as one of the leading causes of dyshormonogenesis. Differently, DUOXA defects seem to be rarely involved in the pathogenesis of CH. Genotype-phenotype correlations are also reported, highlighting the great intra- and inter-familial phenotype variability which appears to be a constant feature of the defects in the HO generation systems. Finally, the hypotheses to explain the phenotypic variability of the DUOX2/A2 mutations are discussed, such as the existence of other HO generating systems, the age variability in thyroid hormones requirements, the differences in ethnicity, in iodine intake, and in the methodological approaches.
在确定甲状腺双氧酶(DUOX)生成系统及其成熟因子(DUOXA)后,DUOX2和/或DUOXA2缺陷迅速被认为是甲状腺激素合成障碍所致先天性甲状腺功能减退症(CH)的可能原因。本综述报告了DUOX2突变的患病率数据,不同系列的数据有所不同,但始终很高,表明DUOX2缺陷是激素合成障碍的主要原因之一。不同的是,DUOXA缺陷似乎很少参与CH的发病机制。还报告了基因型与表型的相关性,突出了家族内和家族间表型的巨大变异性,这似乎是双氧酶生成系统缺陷的一个恒定特征。最后,讨论了解释DUOX2/A2突变表型变异性的假设,例如其他双氧酶生成系统的存在、甲状腺激素需求的年龄变异性、种族、碘摄入量和方法学方法的差异。